Pronađeno: 1-4 / 4 radova

Autori: Kapelios Chris J

>> Prikaži sve rezultate

>> Sve godine

Naslov Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians (Article)
Autori Vazir Ali Kapelios Chris J Agaoglu Elif Metra Marco Lopatin Yury Seferovic Petar M  Mullens Wilfred Filippatos Gerasimos Rosano Giuseppe MC Coats Andrew JS Chioncel Ovidiu 
Info EUROPEAN JOURNAL OF HEART FAILURE, (2023), vol. 25 br. 9, str. 1555-1570
Projekat Conflict of interest: none declared.
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati:
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry (Article)
Autori Kapelios Chris J ... Seferovic Petar M  (broj koautora 19) 
Info EUROPEAN JOURNAL OF HEART FAILURE, (2020), vol. 22 br. 8, str. 1424-1437
Projekat Abbott Vascular Int.Abbott Laboratories; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb; Pfizer Alliance; Daiichi-Sanky
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry (Article)
Autori Kapelios Chris J ... Seferovic Petar M  (broj koautora 19) 
Info EUROPEAN JOURNAL OF HEART FAILURE, (2020), vol. 22 br. 8, str. 1424-1437
Projekat Abbott Vascular Int.Abbott Laboratories; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb; Pfizer Alliance; Daiichi-Sanky
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world (Article)
Autori Kapelios Chris J ... Seferovic Petar M  ... Seferovic Petar M  ... (broj koautora 617) 
Info EUROPEAN JOURNAL OF HEART FAILURE, (2019), vol. 21 br. 11, str. 1383-1397
Projekat Abbott Laboratories; Amgen Cardiovascular; AstraZeneca; Bayer AG; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb and Pfizer Alliance; Daiichi Sankyo Europe GmbHDaiic
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX